Literature DB >> 7496173

A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene.

G Manfredi1, E A Schon, C T Moraes, E Bonilla, G T Berry, J T Sladky, S DiMauro.   

Abstract

We report a patient with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) who harbored a novel missense mutation at mtDNA position 9957 in the gene specifying subunit III of cytochrome c oxidase (COX III). This T-->C transition converted Phe-251, a highly conserved amino acid in the C-terminus of the polypeptide, to Leu. The mutation, which was not present in 107 normal controls or in 57 patients with various mitochondrial diseases, was heteroplasmic in both muscle and blood of the proband and in blood from his asymptomatic mother. These results provide evidence that the MELAS clinical phenotype can be due not only to mutations in mtDNA-encoded tRNA genes, but in polypeptide-coding genes as well.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7496173     DOI: 10.1016/0960-8966(94)00079-o

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  27 in total

Review 1.  Functional, structural, and genetic mitochondrial abnormalities in myocardial diseases.

Authors:  A Brega; J Narula; E Arbustini
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

Review 2.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

Review 3.  Laboratory approach to mitochondrial diseases.

Authors:  D Parra; A González; C Mugueta; A Martínez; I Monreal
Journal:  J Physiol Biochem       Date:  2001-09       Impact factor: 4.158

Review 4.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

Review 5.  Mitochondrial disease in childhood: mtDNA encoded.

Authors:  Russell P Saneto; Margret M Sedensky
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 6.  Mitochondrial encephalomyopathies: what next?

Authors:  S DiMauro
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 7.  Human cytochrome c oxidase: structure, function, and deficiency.

Authors:  J W Taanman
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

8.  Introducing a novel human mtDNA mutation into the Paracoccus denitrificans COX I gene explains functional deficits in a patient.

Authors:  Simona Lucioli; Klaus Hoffmeier; Rosalba Carrozzo; Alessandra Tessa; Bernd Ludwig; Filippo M Santorelli
Journal:  Neurogenetics       Date:  2005-11-12       Impact factor: 2.660

9.  A MELAS syndrome family harboring two mutations in mitochondrial genome.

Authors:  Byung-Ok Choi; Jung Hee Hwang; Joonki Kim; Eun Min Cho; Sun Young Cho; Su Jin Hwang; Hyang Woon Lee; Song Ja Kim; Ki Wha Chung
Journal:  Exp Mol Med       Date:  2008-06-30       Impact factor: 8.718

10.  MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity.

Authors:  M G Hanna; I P Nelson; J A Morgan-Hughes; N W Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.